Association of C-reactive protein and lower urinary tract symptoms in men and women: results from Boston Area Community Health survey
- PMID: 19394490
- PMCID: PMC3551271
- DOI: 10.1016/j.urology.2008.12.012
Association of C-reactive protein and lower urinary tract symptoms in men and women: results from Boston Area Community Health survey
Abstract
Objectives: To determine whether an association exists between C-reactive protein (CRP) levels and lower urinary tract symptoms (LUTS) as assessed by the American Urological Association Symptom Index (AUA-SI) among both men and women, and to determine the association of CRP levels with the individual urologic symptoms comprising the AUA-SI among both men and women.
Methods: The Boston Area Community Health survey used a multistage stratified design to recruit a random sample of 5502 adults aged 30-79 years. Blood samples were obtained from 3752 participants. The analyses were conducted on 1898 men and 1854 women with complete data on CRP levels. Overall LUTS was defined as an AUA-SI of >or=8 (moderate to severe LUTS). The urologic symptoms comprising the AUA-SI were included in the analysis as reports of fairly often to almost always vs non/rarely/a few times.
Results: A statistically significant association was observed between the CRP levels and overall LUTS among both men and women. The pattern of associations between the individual symptoms and CRP levels varied by sex. Nocturia and straining were associated with greater CRP levels among men, and incomplete emptying and weak stream were associated with greater CRP levels among women.
Conclusions: The results of this study have demonstrated an association between CRP levels and LUTS in both men and women. The dose-response relationship between increased CRP levels and an increased odds of LUTS supports the hypothesized role of inflammatory processes in the etiology of LUTS.
Figures
Similar articles
-
Association of urological symptoms and chronic illness in men and women: contributions of symptom severity and duration--results from the BACH Survey.J Urol. 2009 Feb;181(2):694-700. doi: 10.1016/j.juro.2008.10.039. Epub 2008 Dec 16. J Urol. 2009. PMID: 19091335 Free PMC article.
-
Relationship of lifestyle and clinical factors to lower urinary tract symptoms: results from Boston Area Community Health survey.Urology. 2007 Nov;70(5):916-21. doi: 10.1016/j.urology.2007.06.1117. Epub 2007 Oct 24. Urology. 2007. PMID: 17919693 Free PMC article.
-
Are statin medications associated with lower urinary tract symptoms in men and women? Results from the Boston Area Community Health (BACH) Survey.Ann Epidemiol. 2011 Mar;21(3):149-55. doi: 10.1016/j.annepidem.2010.09.002. Ann Epidemiol. 2011. PMID: 21311603 Free PMC article.
-
Are commonly used psychoactive medications associated with lower urinary tract symptoms?Eur J Clin Pharmacol. 2012 May;68(5):783-91. doi: 10.1007/s00228-011-1170-9. Epub 2011 Dec 4. Eur J Clin Pharmacol. 2012. PMID: 22138718 Free PMC article.
-
An investigation of the relationship between sex-steroid levels and urological symptoms: results from the Boston Area Community Health survey.BJU Int. 2007 Aug;100(2):321-6. doi: 10.1111/j.1464-410X.2007.06938.x. Epub 2007 May 17. BJU Int. 2007. PMID: 17506868
Cited by
-
Is high-sensitivity C-reactive protein associated with lower urinary tract symptoms in aging men? Results from the hallym aging study.Korean J Urol. 2012 May;53(5):335-41. doi: 10.4111/kju.2012.53.5.335. Epub 2012 May 18. Korean J Urol. 2012. PMID: 22670193 Free PMC article.
-
Increased serum C-reactive protein level is associated with increased storage lower urinary tract symptoms in men with benign prostatic hyperplasia.PLoS One. 2014 Jan 15;9(1):e85588. doi: 10.1371/journal.pone.0085588. eCollection 2014. PLoS One. 2014. PMID: 24454896 Free PMC article.
-
Non steroidal anti-inflammatory drug use and levels of oestrogens and androgens in men.Clin Endocrinol (Oxf). 2012 Feb;76(2):272-80. doi: 10.1111/j.1365-2265.2011.04188.x. Clin Endocrinol (Oxf). 2012. PMID: 21815903 Free PMC article.
-
Sleep related problems and urological symptoms: testing the hypothesis of bidirectionality in a longitudinal, population based study.J Urol. 2014 Jan;191(1):100-6. doi: 10.1016/j.juro.2013.07.011. Epub 2013 Jul 15. J Urol. 2014. PMID: 23867307 Free PMC article.
-
Benign Prostatic Hyperplasia and Lower Urinary Tract Symptoms: What Is the Role and Significance of Inflammation?Curr Urol Rep. 2019 Aug 3;20(9):54. doi: 10.1007/s11934-019-0917-1. Curr Urol Rep. 2019. PMID: 31377881 Free PMC article. Review.
References
-
- Boyle P, Robertson C, Mazzetta C, Keech M, Hobbs FD, Fourcade R, Kiemeney L, Lee C. The prevalence of lower urinary tract symptoms in men and women in four centres. The UrEpik study. BJU Int. 2003;92:409–14. - PubMed
-
- Kupelian V, Wei JT, O'Leary MP, Kusek JW, Litman HJ, Link CL, McKinlay JB. Prevalence of lower urinary tract symptoms and effect on quality of life in a racially and ethnically diverse random sample: the Boston Area Community Health (BACH) Survey. Arch Intern Med. 2006;166:2381–7. - PubMed
-
- Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, Van Kerrebroeck P, Victor A, Wein A. The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Urology. 2003;61:37–49. - PubMed
-
- Di Silverio F, Gentile V, De Matteis A, Mariotti G, Giuseppe V, Luigi PA, Sciarra A. Distribution of inflammation, pre-malignant lesions, incidental carcinoma in histologically confirmed benign prostatic hyperplasia: a retrospective analysis. Eur Urol. 2003;43:164–75. - PubMed
-
- Kramer G, Marberger M. Could inflammation be a key component in the progression of benign prostatic hyperplasia? Curr Opin Urol. 2006;16:25–9. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous